Anna Rivkin

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Anna Rivkin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Rivkin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Business Officer Stock option (right to buy) 165,000 $942,150 $5.71 30 Jan 2026 Direct

Insider Reports Filed by Anna Rivkin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FHTX Foghorn Therapeutics Inc. 30 Jan 2026 1 +$942,150 4 Chief Business Officer 02 Feb 2026, 16:02
FHTX Foghorn Therapeutics Inc. 22 Jan 2025 1 +$218,500 4 Chief Business Officer 24 Jan 2025, 16:11
FHTX Foghorn Therapeutics Inc. 03 Sep 2024 1 +$1,491,500 4 Chief Business Officer 04 Sep 2024, 16:02
FHTX Foghorn Therapeutics Inc. 03 Sep 2024 0 $0 3 Chief Business Officer 04 Sep 2024, 16:00